C81.4 Category · further specificity required Lymphocyte-rich Hodgkin lymphoma
ICD-10-CM C81.4 identifies “Lymphocyte-rich Hodgkin lymphoma” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Inclusion terms1
Lymphocyte-rich classical Hodgkin lymphoma
Excludes 11
nodular lymphocyte predominant Hodgkin lymphoma (C81.0-)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C81 · Hodgkin lymphoma
Excludes 11
personal history of Hodgkin lymphoma (Z85.71)
More specific codes
C81.40Lymphocyte-rich Hodgkin lymphoma, unspecified siteBillable / specificC81.41Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neckBillable / specificC81.42Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodesBillable / specificC81.43Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodesBillable / specificC81.44Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limbBillable / specificC81.45Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limbBillable / specificC81.46Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodesBillable / specificC81.47Lymphocyte-rich Hodgkin lymphoma, spleenBillable / specificC81.48Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sitesBillable / specificC81.49Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sitesBillable / specificC81.4ALymphocyte-rich Hodgkin lymphoma, in remissionBillable / specificOfficial index references
Official index references (2)
Lymphoma(of) (malignant) (2)
History
Code history
Latest recorded change · FY2017
ChangedUnchanged
FY2017
Effective from
- Title changed
- Code-level rules changed
Lymphocyte-rich Hodgkin lymphoma
Previous title: Lymphocyte-rich classical Hodgkin lymphoma
Category — select a more specific code
CDC/NCHS · FY2017All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | Title changed · Code-level rules changed |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.